Literature DB >> 16627923

Malignant paraganglioma of the urinary bladder: Immunohistochemical study of prognostic indicators.

Kalman Kovacs1, David Bell, Geoffrey W Gardiner, R John Honey, Jeannette Goguen, Fabio Rotondo.   

Abstract

Using various immunohistochemical markers, the objective of our study was to assess whether correlation exists between growth potential of paraganglioma (pheochromocytoma) cells and formation of metastasis. The patient was a 28-yr-old man who presented with intermittent episodes of gross hematuria due to a mass in the urinary bladder. He had no constitutional symptoms to suggest paraganglioma. Histologic, immunohistochemical, and electron microscopic investigation of the surgically removed tissue proved that the tumor was a malignant paraganglioma with metastases in the regional lymph nodes. The immunohistochemical tests were not supportive of high cell proliferation index, indicating that metastases can develop in the absence of rapid multiplication of the tumor cells. Abnormalities in vascular architecture and marked expression of VEGF in the tumor cells may be regarded as prognostic signs to predict the formation of metastases.

Entities:  

Mesh:

Year:  2005        PMID: 16627923     DOI: 10.1385/ep:16:4:363

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  31 in total

1.  Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization.

Authors:  K Kovacs; L Stefaneanu; E Horvath; R V Lloyd; I Lancranjan; M Buchfelder; R Fahlbusch
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 2.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

3.  Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization.

Authors:  K Kovacs; R Lloyd; E Horvath; S L Asa; L Stefaneanu; D W Killinger; H S Smyth
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

4.  The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas.

Authors:  K Y Lam; C Y Lo; N M Wat; J M Luk; K S Lam
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

5.  Paraganglioma of the urinary bladder: can biologic potential be predicted?

Authors:  L Cheng; B C Leibovich; J C Cheville; D M Ramnani; T J Sebo; R M Neumann; A G Nascimento; H Zincke; D G Bostwick
Journal:  Cancer       Date:  2000-02-15       Impact factor: 6.860

6.  Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?

Authors:  E van der Harst; H A Bruining; H Jaap Bonjer; F van der Ham; W N Dinjens; S W Lamberts; W W de Herder; J W Koper; T Stijnen; C Proye; M Lecomte-Houcke; F T Bosman; R R de Krijger
Journal:  J Pathol       Date:  2000-06       Impact factor: 7.996

7.  Distribution of chromogranin and S100 protein in normal and abnormal adrenal medullary tissues.

Authors:  R V Lloyd; M Blaivas; B S Wilson
Journal:  Arch Pathol Lab Med       Date:  1985-07       Impact factor: 5.534

8.  Comparison of adrenal and extraadrenal pheochromocytomas.

Authors:  R F Pommier; J T Vetto; K Billingsly; E A Woltering; M F Brennan
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

9.  Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon.

Authors:  N Cheung; M P Wong; S T Yuen; S Y Leung; L P Chung
Journal:  Hum Pathol       Date:  1998-09       Impact factor: 3.466

10.  Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma.

Authors:  T Torimura; M Sata; T Ueno; M Kin; R Tsuji; K Suzaku; O Hashimoto; H Sugawara; K Tanikawa
Journal:  Hum Pathol       Date:  1998-09       Impact factor: 3.466

View more
  6 in total

1.  Non-functional paraganglioma of the urinary bladder: a case report.

Authors:  Dan-Feng Xu; Ming Chen; Yu-Shan Liu; Yi Gao; Xin-Gang Cui
Journal:  J Med Case Rep       Date:  2010-07-19

Review 2.  Neuroendocrine Tumors of the Urinary Bladder According to the 2016 World Health Organization Classification: Molecular and Clinical Characteristics.

Authors:  Erik Kouba; Liang Cheng
Journal:  Endocr Pathol       Date:  2016-09       Impact factor: 3.943

3.  Non-Functional Paraganglioma of the Urinary Bladder Treated by Transurethral Resection: Report of Two Cases.

Authors:  Richa Katiyar; Saloni Dwivedi; Sameer Trivedi; Shashikant C U Patne; Uday Shankar Dwivedi
Journal:  J Clin Diagn Res       Date:  2016-02-01

4.  Non-functional paraganglioma of urinary bladder managed by transurethral resection.

Authors:  Baochao Zhang; Zhenrui Fu; Liwei Liu; Baomin Qiao; Chunyu Liu
Journal:  Int Braz J Urol       Date:  2019 Sep-Oct       Impact factor: 3.050

5.  Ectopic Cushing's Syndrome Secondary to Metastatic Paraganglioma.

Authors:  R Daya; C Wingfield; P Sotshononda; F Seedat; S Bulbulia; M D Simmons; M Louw; Z Bayat
Journal:  Case Rep Endocrinol       Date:  2021-06-24

6.  Non-functioning paraganglioma of the urinary bladder: A case report and review of the literature.

Authors:  Yongqing Lai; Duqun Chen; Zuhu Yu; Liangchao Ni; Shangqi Yang
Journal:  Oncol Lett       Date:  2014-01-10       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.